top of page
deliverysystem_vignette.jpg

Groundbreaking innovation

The SpyGlass Pharma™ Drug Delivery Platform combines safe, lasting treatment with the world's most common, routine ophthalmic surgery.

Spyglass Platform Pipeline

Spyglass-Platform-Pipeline-20250321_edit
texture_bg.jpg

SpyGlass Pharma Appoints Anand Sundaram as Head of Commercial

ALISO VIEJO, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma, a late-stage biopharmaceutical company, today announced the appointment of Anand Sundaram as the company’s Vice President, Head of Commercial. Mr. Sundaram brings over a decade of commercial launch experience for ophthalmic treatments. At SpyGlass, he will help build and oversee the Commercial organization and launch preparation as the Company progresses its late-stage Drug Delivery Platform into two Phase III trials and towards potential commercialization. (View full press release)

Spyglass Pharma Logo - Long - Black_edited.png

Technology

Tel: 949-284-6904

About

27061 Aliso Creek Rd, Suite 100
Aliso Viejo, CA 92656

Investors

CONTACT US

SUBSCRIBE

Sign up to receive SpyGlass Pharma™ news and updates.

Thanks for submitting!

© 2025 SpyGlass Pharma™. All Rights Reserved.

Follow us on LinkedIn

  • LinkedIn
bottom of page